Skip to main content

Animations

MJFF Publications

5411 - 5420 of 9148 Results
Title
Year
  • Year
  • 2019
  • 2024
  • 2025
  • 2026
  • 2025
  • 2024
  • 2023
  • 2018
  • 2018
  • 2021
  • Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    2019
    Summary Details
    OPEN
    Title: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982
    Citation Count: 75
  • Summary Details
    OPEN
    Title: The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2023.12.024
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30280
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Benchmarking privacy and utility in synthetic tabular cohorts for Alzheimer's disease research
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/dad2.70430
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116145
    Citation Count: 6
  • Summary Details
    OPEN
    Title: A genetic and proteomic comparison of key AD biomarkers across tissues
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.14139
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370
    Citation Count: 15
  • Summary Details
    OPEN
    Title: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00417
    Citation Count: 46
  • Summary Details
    OPEN
    Title: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00064
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagy
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.abg4922
    Citation Count: 55
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.